H. Lee Moffitt Cancer Center & Research Institute M2Gen Board of Directors

Where You Are:

The M2Gen Board oversees the collaboration between Moffitt and Merck & Co., Inc., that seeks to expand Moffitt’s efforts in research and biotechnology while developing and commercializing the means to prescribe and deliver personalized cancer care. This innovative collaboration is developing one of the largest tissue bio-repositories and relational databases in the country, with the goal of combining molecular profiling technology with clinical response to improve cancer prevention, diagnosis and treatment.

 

Theodore J. Couch, Sr., Chair

 

 

Senator Connie Mack, Vice Chair
Liberty Partners Group

William S. Dalton, Ph.D., M.D.
CEO, M2Gen
Director, Personalized Medicine Institute, Moffitt Cancer Center

 

Ken Ford

Kenneth Ford, Ph.D.
Founder and CEO
Florida Institute for Human & Machine Cognition

Jack A. Kolosky
Executive Vice President
Chief Operating Officer
President, Moffitt Hospital

 

Kenneth I. Moch
Businessman

Lee Moffitt

The Honorable H. Lee Moffitt
Former Speaker, Florida House of Representatives;
Founder, H. Lee Moffitt Cancer Center & Research Institute
 

 

Linda Powers

Linda Powers
Tucan Capital Fund

Robert Rothman
CEO/President,
Black Diamond Group

 

 

 

Dr. Daniel Sullivan

Daniel Sullivan, M.D.
Associate Center Director for Clinical Investigations,
H. Lee Moffitt Cancer Center & Research Institute; Chief Medical Officer, M2Gen

 
 
 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer